Table 2.
Diagnosis | Post-dose parameters |
No disease | FEV1/FVC ≥ 0.70 |
COPD GOLD stage: | |
Stage I: Mild | FEV1/FVC < 0.70 FEV1 ≥ 80% predicted |
Stage II Moderate: | FEV1/FVC < 0.70 50% ≤ FEV1 < 80% predicted |
Stage III: Severe | FEV1/FVC < 0.70 30% ≤ FEV1 < 50% predicted |
Stage IV: Very Severe | FEV1/FVC < 0.70 FEV1 < 30% predicted or FEV1 < 50% predicted plus chronic respiratory failure |
FEV1 forced expiratory volume in one second; FVC forced vital capacity; respiratory failure: arterial partial pressure of oxygen (PaO2) less than 8.0 kPa (60 mmHg) with or without arterial partial pressure of CO2 (PaCO2) greater than 6.7 kPa (50 mmHg) while breathing air at sea level